| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.059 | 0.08 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.059 | 0.08 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.077 | 0.09 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.09 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.05 | 0.09 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.087 | 0.09 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.09 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.09 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | -0.05 | 0.1 |